MCL1 and acute myeloid leukemia: Since Noxa promotes Mcl-1 degradation via the BH3-only E3 ubiquitin ligase Mule,53 Mcl-1 levels might be expected to rise in bortezomib-treated cells but this was not apparent for the AML lines (Figure 4a).